PMAD

In Brief: ACOG Recommends Increased Level of Care During the “Fourth Trimester”

The American College of Obstetricians and Gynecologists (ACOG) has made a significant change to its recommendations for optimal postpartum care.  Previously, ACOG has recommended that women receive a single, comprehensive postpartum visit within the first [...]

Announcing the MGH Perinatal Depression Scale at the App Store

We are very pleased to announce the release of the MGH Perinatal Depression Scale available free of charge on the App Store (https://appsto.re/us/-3X4jb.i). The MGHPDS smartphone app includes digital versions of perinatal depression screening tools [...]

Brexanolone: Related to Allopregnanolone, Effective for the Treatment of Postpartum Depression

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression.  SAGE-547, now called brexanolone, is an allosteric modulator of GABAA receptors.  This drug was initially under [...]